Taken together, combining comprehensive bioinformatics and preclinical animal model results, we show that ZDHHC3 deficiency can inhibit pancreatic cancer progression by enhancing anti-tumor immunity. Here, ZDHHC3 is linked to pancreatic neoplasm.